Daniel Donovan - 15 Jun 2022 Form 3 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role
Director
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Issuer symbol
PBLA
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
3
Filing time
24 Jun 2022, 16:46:58 UTC
Next filing
29 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PBLA Common Stock 71,535 15 Jun 2022 Direct
holding PBLA Common Stock 163,256 15 Jun 2022 By GDB Investments, LLP F1
holding PBLA Common Stock 75,528 15 Jun 2022 By Westport Boys, LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PBLA Stock Option (right to buy) 15 Jun 2022 Common Stock 37,320 $0.2200 Direct F2
holding PBLA Stock Option (right to buy) 15 Jun 2022 Common Stock 22,214 $0.2200 Direct F2
holding PBLA Warrants (right to buy) 15 Jun 2022 Common Stock 5,183 $6.76 By GDB Investments, LLP F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F2 Fully vested.

Remarks:

Exhibit List: Power of Attorney EX-24